Checkpoint Therapeutics
Checkpoint | A Fortress Biotech Company.
Market cap
$371m
Enterprise value
$338m
Share price
$4.26 CKPT
loading funding rounds…
| USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 103 % | (51 %) | (37 %) | (75 %) | (28 %) | (46 %) | (60 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (1048 %) | (1455 %) | (2170 %) | (21165 %) | (28064 %) | (50840 %) | (136822 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (1037 %) | (1447 %) | (2159 %) | (21146 %) | (32617 %) | (50337 %) | (137171 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 960 % | 1131 % | 1530 % | 18079 % | 25951 % | 42297 % | 88176 % |
Source: Company filings or news article
Related Content
More about Checkpoint Therapeutics
EditCheckpoint Therapeutics is revolutionizing the way novel treatments for cancer patients are developed. As a fast-follower, our streamlined approach lowers risk and accelerates the development and commercialization of oncology drugs, ensuring more patients, payors and providers benefit from effective and more affordable treatment options.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.